Dr Ndaba Mazibuko
Care Oncology Clinic, Kings College London
Dr Ndaba Mazibuko is a Clinical Research Fellow in Clinical Neuroscience (Institute of Psychiatry, Psychology and Neuroscience - King''s College London). His work includes clinical trial design, management and data analysis with respect to pharmacological and neuro-imaging studies in both the academic and industry sectors. For the last three years he has also collaborated with the SEEK GROUP and The Care Oncology Clinic in the area of Metabolic Repurposed Drug Analysis and Novel Vaccine Development, with respect to both scientific research and direct clinical application.
His academic position includes medical student clinical rotation tutoring and periodic lectures for Kings College London. Prior to that he was a Neurology and Acute Stroke Registrar at King''s College Hospital and has several years’ experience as a clinician in varied disciplines within the NHS in addition to clinical experience in Australia (where he trained) and also in Africa.
Drug Repurposing In Practice: Metabolic Pleiotropism in Glioblastoma Management
Care Oncology Clinic (COC) has been set up to enable the use of off-label drugs by Physicians to treat cancer patients as an adjunct to their standard of care. COC has developed a protocol which comprises a combination of four generic metabolic modulating medicines. These medicines have excellent safety profiles and well-established anti-cancer effects in pluralistic peer-review literature. COC’s analysis seeks to contribute to this emerging data.
EVEN MORE SEMINARS
Philip Beer MRCP, FRCPath, PhD ONCODNA S.A
The evolution of oncology therapeutics in the genomic era.
Prof Adam Waldman MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging
Biomarkers in Adult Glioma
Mr Naga Venkatesh Jayanthi MD, FRCS Bupa - Consultant Surgeon
Minimal Invasive Oesophagectomy – where are we going?
Michael Schreiber Brain Tumor Foundation, Chairman
Brain Tumors - Innovation, support and advocacy
Merina Ahmed Royal Marsden NHS foundation Trust
Stereotactic Radiotherapy for lung tumours and oligometastatic disease